EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Magnitude and Durability of Respiratory Syncytial Virus-Specific Immune Responses Three Years After Hospitalization for RSV-Associated Acute Respiratory Illness Among Adults ≥50 Years

Caroline R Ciric, Ashley Tippett iD, Binh Ha, Theda Gibson, Ranjini Sankaranarayanan iD, Luis W Salazar iD, Chris Choi, Elizabeth Begier iD, Robin Hubler, Qing Liu, Sonal Uppal, Bradford D Gessner iD und 9 weitere

The Journal of Infectious Diseases · 11.11.2026

DOI: 10.1093/infdis/jiag542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 11.11.2026. Verfasst von Caroline R Ciric und 20 weiteren Autor:innen. Beteiligte Einrichtung: Emory University School of Medicine, Atlanta, Georgia, USA. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Emory University, Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding immune responses to respiratory syncytial virus (RSV) natural infection in older adults could help inform the need for vaccination, as neutralizing antibodies correlate with protection in this high-risk population.

Methods

Adults ≥50 years of age hospitalized with acute respiratory illness were prospectively enrolled (September 2018–March 2020) at 2 Atlanta, Georgia hospitals. Nasopharyngeal and oropharyngeal swabs were analyzed, and standard-of-care RSV results were recorded. Follow-up visits occurred in early convalescence (V2), at the start of the next respiratory season (SS2), and 2 and 3 years postinfection. Sera were analyzed for RSV-binding IgG by enzyme immunoassay and RSV-A2 and RSV-B1 by neutralization assays. Antibody decay was measured by linear regression of log2-transformed titers. Peripheral blood mononuclear cells were analyzed for T-cell responses by intracellular cytokine staining.

Results

Nineteen RSV-positive and 11 RSV-negative participants were eligible for analysis. For RSV-positive participants, RSV IgG and neutralizing antibodies peaked in early convalescence and gradually waned through 3-year follow-up. RSV IgG titers declined by −0.08 log2 per month, while RSV-A and RSV-B neutralizing antibody titers declined by −0.05log2 per month and were statistically equivalent to RSV-negative participants by the SS2 visit. For RSV-negative participants, minimal changes in antibody titers were observed over time. No significant differences were seen in RSV-specific T-cell responses from SS2 to 2- and 3-year follow-up among either group.

Conclusions

RSV-binding and neutralizing antibodies were transiently elevated following natural infection in older adults but waned to levels similar to RSV-negative participants by the next season's start. Vaccines that counter waning immunity are needed in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

IgGRespiratory syncytial virusT cellscellular immune responseselderlyneutralizing antibodiesolder adults

Autor:innen und Institutionen

  • Emory University School of Medicine, Atlanta, Georgia, USA.
  • Pfizer Inc., Collegeville, Pennsylvania, USA.
  • Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Hope Clinic, Emory Vaccine Center, Atlanta, Georgia, USA.

ORCID-Profile: Ashley Tippett, Ranjini Sankaranarayanan, Luis W Salazar, Elizabeth Begier, Bradford D Gessner, David Swerdlow, Benjamin Lopman, Satoshi Kamidani, Nadine Rouphael, Larry J Anderson, Evan J Anderson, Christina A Rostad

Förderung

  • Emory University
  • Pfizer

Zitieren

APA

Ciric, C. R., Tippett, A., Ha, B., Gibson, T., Sankaranarayanan, R., Salazar, L. W., Choi, C., Begier, E., Hubler, R., Liu, Q., Uppal, S., Gessner, B. D., Swerdlow, D., Kalina, W. V., Lopman, B., Kamidani, S., Chen, X., Rouphael, N., Anderson, L. J., …, & Rostad, C. A. (2026). Magnitude and Durability of Respiratory Syncytial Virus-Specific Immune Responses Three Years After Hospitalization for RSV-Associated Acute Respiratory Illness Among Adults ≥50 Years. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag542

Vancouver

Ciric CR, Tippett A, Ha B, Gibson T, Sankaranarayanan R, Salazar LW, et al. Magnitude and Durability of Respiratory Syncytial Virus-Specific Immune Responses Three Years After Hospitalization for RSV-Associated Acute Respiratory Illness Among Adults ≥50 Years. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag542

BibTeX
@article{Ciric2026,
  author = {Ciric, Caroline R and Tippett, Ashley and Ha, Binh and Gibson, Theda and Sankaranarayanan, Ranjini and Salazar, Luis W and Choi, Chris and Begier, Elizabeth and Hubler, Robin and Liu, Qing and Uppal, Sonal and Gessner, Bradford D and Swerdlow, David and Kalina, Warren V and Lopman, Benjamin and Kamidani, Satoshi and Chen, Xuemin and Rouphael, Nadine and Anderson, Larry J and Anderson, Evan J and Rostad, Christina A},
  title = {Magnitude and Durability of Respiratory Syncytial Virus-Specific Immune Responses Three Years After Hospitalization for RSV-Associated Acute Respiratory Illness Among Adults ≥50 Years},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag542}
}
Kostenlos starten →